BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Hypothalamus, Alcohol, Trichostatin A, rs7903146, SNCA, cell-cell adhesion)
Bookmark Forward

QuickView for nicotinic cholinergic agonists (compound)


Genetic Markers

Most Correlated Genes

  1. CHRNA2
  2. MMP7
  3. AFF1
  4. KCNB1
  5. NUCKS1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. heterocyclic compound binding
  2. organic cyclic compound binding
  3. PUJANA_BRCA1_PCC_NETWORK
  4. DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
  5. KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Effects of nicotine on the palate development
  2. Oral keratinocytes treated with ethanol and nicotine
  3. Prostate cancer cell lines treated with nicotine
  4. Prostate of TRAMP mice exposed to nicotine
  5. Liver, breast and endometrial cell lines exposed to 34 toxicological compounds
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acu…
  2. Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with d…
  3. Partial agonists for α4β2 nicotinic receptors stimulate dopaminergic neuron firing with relatively e…
  4. A fluorinated quinuclidine benzamide named LMA 10203 acts as an agonist of insect nicotinic acetylch…
  5. The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
  2. Nicotine Effects on Endophenotypes of Schizophrenia
  3. Depressed Mood Improvement Through Nicotine Dosing 2
  4. Depressed Mood Improvement Through Nicotine Dosing 3
  5. Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.